CryoLife : Appoints James McDermid as Chief Human Resources Officer
September 17, 2016 at 05:49 am EDT
Share
ATLANTA, Sept. 6, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today the appointment of James McDermid to the position of Chief Human Resources Officer, effective immediately. Mr. McDermid joins the company from Medtronic where he was Group Vice President, Human Resources for the Cardiac and Vascular Group. He will report to Pat Mackin, Chairman, President, and Chief Executive Officer.
Mr. Mackin commented, 'Jim has a proven track record as a human resources leader and we are fortunate to have him join the CryoLife team. Given his experience leading the HR team for one of the largest cardiovascular businesses in the world, he is well positioned to enhance CryoLife's HR programs as we continue to grow our business. I worked personally with Jim in my time at Medtronic and am confident that he will add a valuable perspective and be a driving force in further improving the experience and development opportunities for our employees around the world.'
Mr. McDermid has over 25 years of experience in Human Resources leadership. Prior to joining CryoLife, he served as Group Vice President, Human Resources, Cardiac & Vascular Group at Medtronic, a global leader in medical technology, services, and solutions. Prior to that, he held the positions of Sector Vice President, Human Resources; Vice President, Human Resources; and Director, Human Resources at Medtronic from 1998 to 2001. Earlier in his career, Mr. McDermid served in human resources roles with International Paper Company and Cooper Industries. Mr. McDermid received a Bachelor's degree from the University of Toronto and a Master's degree from McMaster University.
About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
Logo - http://photos.prnewswire.com/prnh/20140319/MM86518LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryolife-appoints-james-mcdermid-as-chief-human-resources-officer-300322253.html
SOURCE CryoLife, Inc.
CryoLife Inc. published this content on 17 September 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 September 2016 09:48:07 UTC.
Original documenthttp://phx.corporate-ir.net/phoenix.zhtml?c=80253&p=irol-newsArticle&ID=2203842
Public permalinkhttp://www.publicnow.com/view/CB36480518D4EB0776B31A7B8F031AFFABDC105F
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
ARTIVION, INC. 
